688331 荣昌生物
已收盘 11-12 15:00:00
资讯
新帖
简况
股市必读：荣昌生物新发布《荣昌生物关于取得金融机构股票回购专项贷款承诺函的公告》
证券之星 · 01:04
股市必读：荣昌生物新发布《荣昌生物关于取得金融机构股票回购专项贷款承诺函的公告》
荣昌生物：与Vor Bio签署RC298许可协议修订案 获约5600万美元首付款
格隆汇 · 11-12 20:43
荣昌生物：与Vor Bio签署RC298许可协议修订案 获约5600万美元首付款
荣昌生物(09995)与Vor Bio就《许可协议》签署修订协议
智通财经 · 11-12 20:32
荣昌生物(09995)与Vor Bio就《许可协议》签署修订协议
荣昌生物(688331.SH)取得金融机构股票回购专项贷款承诺函
智通财经 · 11-11 16:28
荣昌生物(688331.SH)取得金融机构股票回购专项贷款承诺函
荣昌生物（688331）11月9日主力资金净买入69.49万元
证券之星 · 11-10 08:58
荣昌生物（688331）11月9日主力资金净买入69.49万元
创新药又迎利好！首付5000万元、里程碑最高48.7亿元 荣昌生物引进泛RAS抑制剂全球权益 股价年内上涨26%
每日经济新闻 · 11-09
创新药又迎利好！首付5000万元、里程碑最高48.7亿元 荣昌生物引进泛RAS抑制剂全球权益 股价年内上涨26%
荣昌生物(09995)与烟台荣昌制药订立许可协议
智通财经 · 11-09
荣昌生物(09995)与烟台荣昌制药订立许可协议
荣昌生物新提交“泰爱信”、“泰爱择”等4件商标注册申请
证券之星 · 11-09
荣昌生物新提交“泰爱信”、“泰爱择”等4件商标注册申请
荣昌生物：签署泛RAS(ON)小分子抑制剂全球独占许可协议 将支付首付款5000万元、最高里程碑付款48.7亿元
格隆汇 · 11-09
荣昌生物：签署泛RAS(ON)小分子抑制剂全球独占许可协议 将支付首付款5000万元、最高里程碑付款48.7亿元
荣昌生物（688331）披露2022年A股限制性股票激励计划B类权益预留授予第二个归属期符合归属条件公告，11月05日股价上涨1.62%
证券之星 · 11-05
荣昌生物（688331）披露2022年A股限制性股票激励计划B类权益预留授予第二个归属期符合归属条件公告，11月05日股价上涨1.62%
交银国际：维持荣昌生物(09995)“买入”评级 目标价调整至128港元
智通财经 · 11-04
交银国际：维持荣昌生物(09995)“买入”评级 目标价调整至128港元
荣昌生物早盘涨逾6% 拟3000万元至6000万元回购公司A股
新浪港股 · 11-04
荣昌生物早盘涨逾6% 拟3000万元至6000万元回购公司A股
港股生物医药股逆势上涨，百济神州涨超5%，药明生物、荣昌生物涨超4%
老虎资讯综合 · 11-04
港股生物医药股逆势上涨，百济神州涨超5%，药明生物、荣昌生物涨超4%
荣昌生物（688331）11月3日主力资金净卖出4712.91万元
证券之星 · 11-04
荣昌生物（688331）11月3日主力资金净卖出4712.91万元
贝莱德在荣昌生物的H股好仓比例上升0.05%至5.04%
南方财经网 · 11-03
贝莱德在荣昌生物的H股好仓比例上升0.05%至5.04%
荣昌生物已回购约6万股，耗资约663.2万元
北京商报 · 11-02
荣昌生物已回购约6万股，耗资约663.2万元
荣昌生物(688331.SH)拟3000万元至6000万元回购公司A股股份
智通财经 · 11-02
荣昌生物(688331.SH)拟3000万元至6000万元回购公司A股股份
荣昌生物：截至2026年10月31日公司累计回购股份6.00万股
南方财经网 · 11-02
荣昌生物：截至2026年10月31日公司累计回购股份6.00万股
荣昌生物副总裁李栋：每一次对外合作都是锻长板、补短板
证券日报 · 11-01
荣昌生物副总裁李栋：每一次对外合作都是锻长板、补短板
荣昌生物(688331)9月30日股东户数2.75万户，较上期增加13.52%
证券之星 · 10-30
荣昌生物(688331)9月30日股东户数2.75万户，较上期增加13.52%
加载更多
公司概况
公司名称：
荣昌生物制药(烟台)股份有限公司
所属行业：
医药制造业
上市日期：
2022-03-31
主营业务：
荣昌生物制药(烟台)股份有限公司的主营业务是研发、生产和销售医药产品、诊断试剂产品。公司的主要产品是泰它西普、维迪西妥单抗、RC28、RC148、RC118、RC278、RC288。
发行价格：
48.00
{"stockData":{"symbol":"688331","market":"SH","secType":"STK","nameCN":"荣昌生物","latestPrice":98.34,"timestamp":1794466800000,"preClose":99.23,"halted":0,"volume":5620830,"delay":0,"changeRate":-0.009,"floatShares":356000000,"shares":564000000,"eps":11.5746,"marketStatus":"已收盘","change":-0.89,"latestTime":"11-12 15:00:00","open":99.23,"high":101.06,"low":97.66,"amount":557000000,"amplitude":0.0343,"askPrice":98.35,"askSize":2,"bidPrice":98.34,"bidSize":255,"shortable":0,"etf":0,"ttmEps":11.5746,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794533400000},"marketStatusCode":5,"adr":0,"adjPreClose":99.23,"symbolType":"stock_kcb","openAndCloseTimeList":[[1794447000000,1794454200000],[1794459600000,1794466800000]],"highLimit":109.15,"lowLimit":89.31,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":564477483,"isCdr":false,"pbRate":6.24,"roa":"--","peRate":8.49619,"roe":"84.13%","epsLYR":1.29,"committee":0.509972,"marketValue":55511000000,"turnoverRate":0.0158,"status":1,"afterMarket":{"amount":39336,"volume":400,"close":98.34,"buyVolume":0,"sellVolume":0,"time":1794468837746,"indexStatus":"已收盘 11-12 15:30:00","preClose":99.23},"hkstockBrief":{"symbol":"09995","market":"HK","secType":"STK","nameCN":"荣昌生物","latestPrice":69.35,"timestamp":1794470886010,"preClose":69.95,"halted":0,"volume":1133715,"delay":0,"premium":"-40.01"},"floatMarketCap":34999000000},"requestUrl":"/m/hq/s/688331","defaultTab":"news","newsList":[{"id":"2683165185","title":"股市必读：荣昌生物新发布《荣昌生物关于取得金融机构股票回购专项贷款承诺函的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2683165185","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2683165185?lang=zh_cn&edition=full","pubTime":"2026-11-13 01:04","pubTimestamp":1794503058,"startTime":"0","endTime":"0","summary":"公司公告汇总荣昌生物关于取得金融机构股票回购专项贷款承诺函的公告荣昌生物制药（烟台）股份有限公司于2026年11月2日召开第三届董事会第六次会议，审议通过2026年第二次以集中竞价交易方式回购公司股份的方案，拟回购资金总额不低于3,000万元且不超过6,000万元，回购价格不超过131元/股，期限为董事会审议通过之日起3个月内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111300001692.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","LU1969619763.USD","09995","LU2488822045.USD","LU1064131003.USD","BK1583","BK1574","LU2148510915.USD","LU2328871848.SGD","688331","BK1161","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682595774","title":"荣昌生物：与Vor Bio签署RC298许可协议修订案 获约5600万美元首付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2682595774","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682595774?lang=zh_cn&edition=full","pubTime":"2026-11-12 20:43","pubTimestamp":1794487380,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU2488822045.USD","LU2148510915.USD","BK0239","BK1161","BK1574","LU1064131003.USD","LU2328871848.SGD","09995","688331","LU1064130708.USD","BK1583","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682959395","title":"荣昌生物(09995)与Vor Bio就《许可协议》签署修订协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2682959395","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682959395?lang=zh_cn&edition=full","pubTime":"2026-11-12 20:32","pubTimestamp":1794486742,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物 发布公告，为进一步丰富许可协议项下双方在全球自身免疫领域的产品组合、加速本公司创新管线的国际化开发，于2026年11月12日，本公司与Vor Bio就许可协议签署修订协议，将本公司具有自主知识产权的RC298纳入合作范围，Vor Bio 将获得在全球开发及商业化RC298的独家权利。现有许可协议项下的销售里程碑及特许权使用费机制将继续适用，并基于全部许可产品的汇总销售额进行计算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1522519.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","BK1583","LU2148510915.USD","688331","LU2328871848.SGD","09995","LU1064131003.USD","LU1064130708.USD","BK1574","BK1161","LU1969619763.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682371432","title":"荣昌生物(688331.SH)取得金融机构股票回购专项贷款承诺函","url":"https://stock-news.laohu8.com/highlight/detail?id=2682371432","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682371432?lang=zh_cn&edition=full","pubTime":"2026-11-11 16:28","pubTimestamp":1794385696,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(688331.SH)发布公告，公司此前拟3000万元至6000万元回购股份。近日，公司取得上海浦东发展银行股份有限公司烟台分行出具的《贷款承诺函》，贷款金额：不超过5400万元且不得超过实际回购金额的90%，贷款期限：不超过3年，贷款用途：专项用于回购公司股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1521610.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09995","BK0239","SPHQ","FISI","BK1574","DIVB","PKW","LU1064130708.USD","BK1161","LGCF","BK4585","ACTV","BUYB","688331","SHRY","LU2328871848.SGD","LU2148510915.USD","FYLD","BK1583","SYLD","LU2488822045.USD","LYLD","LU1064131003.USD","BK4211","BK4588","MYLD","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682832355","title":"荣昌生物（688331）11月9日主力资金净买入69.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682832355","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682832355?lang=zh_cn&edition=full","pubTime":"2026-11-10 08:58","pubTimestamp":1794272285,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月9日收盘，荣昌生物报收于98.02元，上涨2.96%，换手率2.05%，成交量7.28万手，成交额7.19亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入3985.29万元，融资偿还4434.69万元，融资净偿还449.4万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026111000010412.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","LU2488822045.USD","LU1064130708.USD","LU1969619763.USD","09995","BK1161","BK0239","LU2328871848.SGD","LU1064131003.USD","LU2148510915.USD","688331","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682138269","title":"创新药又迎利好！首付5000万元、里程碑最高48.7亿元 荣昌生物引进泛RAS抑制剂全球权益 股价年内上涨26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2682138269","media":"每日经济新闻","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682138269?lang=zh_cn&edition=full","pubTime":"2026-11-09 23:15","pubTimestamp":1794237352,"startTime":"0","endTime":"0","summary":"荣昌生物（SH688331，股价98.02元，市值474.72亿元）2026年11月9日盘后发布公告，公司当日（交易时段后）与烟台荣昌制药股份有限公司（下称荣昌制药）签署《许可协议》。上市公司方面获授权引进泛RAS（ON）小分子抑制剂及其作为活性药物成分的全部产品在全球范围内的独占性权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611093926593847.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611093926593847.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09995","BK1574","06978","BK1583","LU1064130708.USD","LU2148510915.USD","IBBQ","BK1161","159992","LU1969619763.USD","LU1064131003.USD","BK0239","MEDX","LU2488822045.USD","LNGR","688331","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682386531","title":"荣昌生物(09995)与烟台荣昌制药订立许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2682386531","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682386531?lang=zh_cn&edition=full","pubTime":"2026-11-09 21:35","pubTimestamp":1794231357,"startTime":"0","endTime":"0","summary":"据悉，许可方拥有与泛RAS小分子抑制剂项目有关的若干权利及知识产权。于2023年，当许可方拟进行RCZY-690的开发工作时，有关机会已提呈予该公司垂注。经考虑RCZY-690作为小分子肿瘤产品的性质且尚处于新药早期开发阶段，研发风险较高后，公司并没有承接该项目机会。其后，许可方利用其本身资源继续进行RCZY-690的研究及开发。公司意识到，订立许可协议或会涉及若干潜在不利因素。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1520715.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2328871848.SGD","LU2488822045.USD","LU1064130708.USD","LU2148510915.USD","01477","09995","688331","BK1574","BK1583","LU1064131003.USD","BK1191","BK1161","BK0239","LU1969619763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682438592","title":"荣昌生物新提交“泰爱信”、“泰爱择”等4件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2682438592","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682438592?lang=zh_cn&edition=full","pubTime":"2026-11-09 21:18","pubTimestamp":1794230313,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示，近日荣昌生物制药（烟台）股份有限公司新提交“泰爱信”、“泰爱择”等4件商标注册申请。商标申请详情如下：今年以来荣昌生物制药（烟台）股份有限公司新申请注册商标8件，截止目前公司共持有注册商标136件，另有47件商标尚在注册申请中。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110900021065.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","688331","09995","LU1064131003.USD","BK1574","LU2148510915.USD","BK1583","LU1064130708.USD","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2682880963","title":"荣昌生物：签署泛RAS(ON)小分子抑制剂全球独占许可协议 将支付首付款5000万元、最高里程碑付款48.7亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2682880963","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2682880963?lang=zh_cn&edition=full","pubTime":"2026-11-09 20:40","pubTimestamp":1794228050,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["688331","09995","BK1583","BK0239","BK1574","LU1064130708.USD","LU1969619763.USD","BK1161","LU2148510915.USD","LU2328871848.SGD","LU2488822045.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681079233","title":"荣昌生物（688331）披露2022年A股限制性股票激励计划B类权益预留授予第二个归属期符合归属条件公告，11月05日股价上涨1.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681079233","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2681079233?lang=zh_cn&edition=full","pubTime":"2026-11-05 22:07","pubTimestamp":1793887638,"startTime":"0","endTime":"0","summary":"截至2026年11月5日收盘，荣昌生物报收于97.21元，较前一交易日上涨1.62%，最新总市值为548.73亿元。公告显示，公司2022年A股限制性股票激励计划之B类权益预留授予第二个归属期归属条件已成就。本次拟归属限制性股票数量为18.022万股，来源为公司向激励对象定向发行A股普通股，授予价格36.36元/股。共有8名激励对象符合归属条件，其中包含1名董事、高级管理人员，其余为其他员工。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110500042929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03130","BK0239","LU2488822045.USD","02822","02843","09995","LU1064130708.USD","02823","02827","82823","83188","LU1969619763.USD","BK1610","BK1161","159982","82843","82822","83130","03188","LU2328871848.SGD","688331","LU1064131003.USD","07233","BK1147","BK1574","BK1583","LU2148510915.USD","399300","02846","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680081628","title":"交银国际：维持荣昌生物(09995)“买入”评级 目标价调整至128港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680081628","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680081628?lang=zh_cn&edition=full","pubTime":"2026-11-04 14:20","pubTimestamp":1793773210,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，维持荣昌生物“买入”评级，大幅上调2026年对外许可收入预测，上调2026年、下调2027-28年收入预测，主要反映对外授权交易收入的最新确认节奏，以及基于1-3Q业绩对产品销售预测的调整。基于DCF模型调整目标价至128港元，隐含97%潜在涨幅，短期内丰富催化剂有望驱动估值修复。截至3Q26末，泰它西普和维迪西妥的商业化团队规模分别约900人/500人，年底至明年初将在泰它西普的肾科领域加大团队配置。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518253.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688331","EWH","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680088400","title":"荣昌生物早盘涨逾6% 拟3000万元至6000万元回购公司A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680088400","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680088400?lang=zh_cn&edition=full","pubTime":"2026-11-04 11:38","pubTimestamp":1793763480,"startTime":"0","endTime":"0","summary":"模拟交易客户端荣昌生物早盘涨逾6%，截至发稿，股价上涨5.92%，现报66.25港元，成交额1.283亿港元。11月2日，荣昌生物发布公告，公司董事会审议通过《关于2026年第二次以集中竞价交易方式回购公司股份方案的议案》，拟使用公司自有资金和/或自筹资金通过集中竞价方式回购公司A股股份。回购的股份用于维护公司价值及股东权益。回购股份金额不低于3000万元（含），不超过6000万元（含），回购股份价格不超过131元/股（含）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-11-04/doc-inixpvva1664009.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["82822","BK0239","BK1610","03188","02823","83188","03130","159982","07233","LU1969619763.USD","02843","BK1147","LU1064130708.USD","LU2328871848.SGD","LU1064131003.USD","399300","02822","BK1161","82843","83130","BK1583","02846","LU2148510915.USD","688331","BK1574","LU2488822045.USD","02827","09995","82823","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128695599","title":"港股生物医药股逆势上涨，百济神州涨超5%，药明生物、荣昌生物涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1128695599","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1128695599?lang=zh_cn&edition=full","pubTime":"2026-11-04 09:36","pubTimestamp":1793756176,"startTime":"0","endTime":"0","summary":"11月4日，港股$生物(000504)$医药股逆势上涨，$百济神州(06160)$涨超5%，$药明生物(02269)$、$荣昌生物(09995)$涨超4%，$康方生物(09926)$、$复宏汉霖(02696)$、$药明康德(02359)$涨超3%。、","market":"hk","thumbnail":"https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/fb4be1ff4aaa40ac88564f80f173158e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348784397.USD","LU1046422090.SGD","LU0326950275.SGD","BK4585","LU0229945570.USD","LU2399975544.HKD","LU0979878070.USD","LU2148510915.USD","LU0501845795.SGD","LU2476274720.SGD","LU1969619763.USD","BK1610","BK4139","IE00B0JY6N72.USD","688235","SG9999011746.SGD","LU0043850808.USD","LU0516422366.SGD","399441","LU0516423174.USD","LU1481107354.HKD","HK0000320223.HKD","LU0228659784.USD","KCAI","LU0561508036.HKD","IE00B5MMRT66.SGD","LU0348825331.USD","02696","09939","09926","LU0572944931.SGD","LU1328277881.USD","02359","LU2125910500.SGD","LU1688375341.USD","SG9999002562.SGD","BK1588","LU0348735423.USD","LU0181495838.USD","LU2476274308.USD","HK0000320264.USD","688331","KURE","LU0540923850.HKD","XBI","BK4526","02269","LU0307460666.USD","LU0469268626.HKD","LU0455707207.USD","BK1574","LU0708995153.HKD","LU0516422440.USD","BK1576","LU1064130708.USD","BK1589","LU0128526141.USD","LU0072913022.USD","BK1161","BK1141","LU0320764243.SGD","LU0634319403.HKD","LU0348827113.USD","LU1064131003.USD","09995","LU1961090484.USD","LU0052750758.USD","LU1880383366.USD","BK0239","LU2328871848.SGD","LU0314109678.HKD","LU0502904849.HKD","LU0417516738.SGD","LU3063872942.SGD","LU0417516902.SGD","161726","ONC","LU0823426308.USD","BK1500","06160","LU0348783233.USD","LU0320764599.SGD","LU1242518857.USD","LU0128522744.USD","LU2488822045.USD","VXUS","LU0029874905.USD","HK0000306685.HKD","LU0708995583.HKD","LU1242518931.SGD","HK0000165453.HKD","LU2242644610.SGD","LU0140636845.USD","LU0456846285.SGD","LU1794554557.SGD","LU0543330566.HKD","LU2778985437.USD","LU0348766576.USD","LU0039217434.USD","LU0588546209.SGD","LU0823426480.USD","LU0359202008.SGD","LU1720050803.USD","LU0051755006.USD","LU0828237510.HKD","LU0211977185.USD","LU0516422952.EUR","LU0029874061.USD","LU0456827905.SGD","BK1521","LU2039709279.SGD","LU1770034418.SGD","LU0164880469.USD","LU0348767384.USD","HK0000306701.USD","IE00BFMHRM44.USD","IE00BPRC5H50.USD","LU0149721374.USD","IE00B543WZ88.USD","LU0327786744.USD","LU0516423091.SGD","LU0417516571.SGD","BK4588","LU1303224171.USD","BK1583","LU2045819591.USD","LU0359201612.USD","LU1813983027.USD","LU1251922891.USD","BK4581","LU0856984785.SGD","LU0819121731.USD","SG9999002463.SGD","LU1719994722.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680701708","title":"荣昌生物（688331）11月3日主力资金净卖出4712.91万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680701708","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680701708?lang=zh_cn&edition=full","pubTime":"2026-11-04 08:50","pubTimestamp":1793753434,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月3日收盘，荣昌生物报收于84.9元，下跌8.93%，换手率2.87%，成交量10.23万手，成交额8.82亿元。近5日资金流向一览见下表：荣昌生物融资融券信息显示，融资方面，当日融资买入9610.03万元，融资偿还8285.6万元，融资净买入1324.43万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110400011072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09995","BK1583","LU2488822045.USD","BK0239","688331","LU1064131003.USD","LU2148510915.USD","LU2328871848.SGD","BK1574","LU1969619763.USD","LU1064130708.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680947741","title":"贝莱德在荣昌生物的H股好仓比例上升0.05%至5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680947741","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680947741?lang=zh_cn&edition=full","pubTime":"2026-11-03 17:22","pubTimestamp":1793697720,"startTime":"0","endTime":"0","summary":"南财智讯11月3日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在荣昌生物的H股好仓（L）比例于10月29日从4.99%上升至5.04%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611033920341418.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611033920341418.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","688331","09995","LU1064131003.USD","BK1574","LU2148510915.USD","BK1583","LU1064130708.USD","LU2328871848.SGD","LU2488822045.USD","LU1969619763.USD","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680752428","title":"荣昌生物已回购约6万股，耗资约663.2万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680752428","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680752428?lang=zh_cn&edition=full","pubTime":"2026-11-02 20:23","pubTimestamp":1793622191,"startTime":"0","endTime":"0","summary":"11月2日晚间，荣昌生物（688331）披露公告称，截至10月31日，公司累计回购公司股份约6万股，占公司总股本的约0.01%，回购成交最高价为113.7元/股，最低价为108.3元/股，已支付资金总额约663.2万元（不含交易费用）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611023918962675.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611023918962675.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","BK1574","BK1583","BK0239","688331","LU1064131003.USD","LU2148510915.USD","LU2488822045.USD","BK1161","09995","LU1969619763.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680173241","title":"荣昌生物(688331.SH)拟3000万元至6000万元回购公司A股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2680173241","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680173241?lang=zh_cn&edition=full","pubTime":"2026-11-02 16:57","pubTimestamp":1793609861,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荣昌生物(688331.SH)发布公告，公司董事会审议通过《关于2026年第二次以集中竞价交易方式回购公司股份方案的议案》，拟使用公司自有资金和/或自筹资金通过集中竞价方式回购公司A股股份。回购的股份用于维护公司价值及股东权益。回购股份金额不低于3000万元(含)，不超过6000万元(含)，回购股份价格不超过131元/股(含)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1517147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["82822","399300","LU1969619763.USD","BK1161","02846","159982","82843","09995","83188","BK1583","LU1064130708.USD","BK1574","07233","LU2148510915.USD","02822","LU1064131003.USD","LU2328871848.SGD","02827","BK1147","LU2488822045.USD","BK0239","02843","03130","03188","82823","02823","688331","83130","BK1610","82846"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680673215","title":"荣昌生物：截至2026年10月31日公司累计回购股份6.00万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2680673215","media":"南方财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680673215?lang=zh_cn&edition=full","pubTime":"2026-11-02 16:50","pubTimestamp":1793609400,"startTime":"0","endTime":"0","summary":"南财智讯11月2日电，荣昌生物公告，截至2026年10月31日，公司通过回购专用证券账户以集中竞价交易方式回购股份6.00万股，回购股数占公司目前总股本的0.01%，最高成交价为113.70元/股，最低成交价为108.30元/股，已使用资金总额为663.20万元（不含交易费用）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611023918769974.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611023918769974.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2328871848.SGD","LU1064131003.USD","LU2488822045.USD","BK1583","LU1969619763.USD","LU2148510915.USD","09995","LU1064130708.USD","BK1161","BK0239","BK1574","688331"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680587201","title":"荣昌生物副总裁李栋：每一次对外合作都是锻长板、补短板","url":"https://stock-news.laohu8.com/highlight/detail?id=2680587201","media":"证券日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680587201?lang=zh_cn&edition=full","pubTime":"2026-11-01 19:16","pubTimestamp":1793531760,"startTime":"0","endTime":"0","summary":"荣昌生物副总裁李栋：每一次对外合作都是锻长板、补短板","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202611013917748261.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202611013917748261.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1969619763.USD","BK0239","BK1574","BK1161","688331","LU2148510915.USD","BK1583","09995","LU2328871848.SGD","LU1064130708.USD","LU2488822045.USD","LU1064131003.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679213861","title":"荣昌生物(688331)9月30日股东户数2.75万户，较上期增加13.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679213861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679213861?lang=zh_cn&edition=full","pubTime":"2026-10-30 19:12","pubTimestamp":1793358753,"startTime":"0","endTime":"0","summary":"证券之星消息，近日荣昌生物披露，截至2026年9月30日公司股东户数为2.75万户，较6月30日增加3272.0户，增幅为13.52%。在生物制品行业个股中，荣昌生物股东户数低于行业平均水平，截至9月30日，生物制品行业平均股东户数为3.67万户。从股价来看，2026年6月30日至2026年9月30日，荣昌生物区间跌幅为9.92%，在此期间股东户数增加3272.0户，增幅为13.52%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103000046641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","LU2328871848.SGD","09995","BK1161","LU1969619763.USD","LU2148510915.USD","BK1574","688331","LU2488822045.USD","BK0239","LU1064131003.USD","LU1064130708.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794521021446,"stockEarnings":[{"period":"1week","weight":0.0116},{"period":"1month","weight":-0.0612},{"period":"3month","weight":-0.2491},{"period":"6month","weight":-0.1423},{"period":"1year","weight":0.1422},{"period":"ytd","weight":0.2642}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0382},{"period":"3month","weight":-0.0691},{"period":"6month","weight":-0.116},{"period":"1year","weight":-0.0861},{"period":"ytd","weight":-0.0789}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"荣昌生物制药(烟台)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27481人(较上一季度增加13.52%)","perCapita":"12950股","listingDate":"2022-03-31","address":"山东省烟台市福山区中国(山东)自由贸易试验区烟台片区烟台开发区北京中路58号","registeredCapital":"56447万元","survey":" 荣昌生物制药(烟台)股份有限公司的主营业务是研发、生产和销售医药产品、诊断试剂产品。公司的主要产品是泰它西普、维迪西妥单抗、RC28、RC148、RC118、RC278、RC288。","listedPrice":48},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荣昌生物,688331,荣昌生物股票,荣昌生物股票老虎,荣昌生物股票老虎国际,荣昌生物行情,荣昌生物股票行情,荣昌生物股价,荣昌生物股市,荣昌生物股票价格,荣昌生物股票交易,荣昌生物股票购买,荣昌生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荣昌生物(688331)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荣昌生物(688331)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}